Leaflet ROXIPER 10mg / 4mg / 1.25mg film-coated tablets

Indicated for: dyslipidemia

Substance: rosuvastatin + perindopril + indapamide (statin lipid-lowering agent + ACE inhibitor + diuretic)

ATC: C10BX13 (Cardiovascular system | Lipid modifying agents, combinations | Lipid modifying agents in combination with other drugs)

Rosuvastatin+perindopril+indapamide is a combination medication used for the treatment of dyslipidemia, hypertension, and the prevention of cardiovascular diseases. Rosuvastatin lowers LDL cholesterol and triglycerides, perindopril is an angiotensin-converting enzyme (ACE) inhibitor that reduces blood pressure, and indapamide is a thiazide diuretic that helps eliminate excess fluids and lower blood pressure.

This combination is taken orally, usually once daily, and is indicated for patients at high cardiovascular risk, including those with hypertension and associated dyslipidemia. It is commonly used to reduce the risk of major cardiovascular events such as myocardial infarction and stroke.

Common side effects include dizziness, nausea, muscle pain, and fatigue. In rare cases, severe adverse reactions such as kidney failure, hyperkalemia, or rhabdomyolysis may occur. Regular monitoring of renal function, blood pressure, and lipid profile is essential.

Rosuvastatin+perindopril+indapamide is a comprehensive therapeutic option for patients with multiple cardiovascular risk factors, offering significant benefits in a single administration.